Skip to content
10-Q

Quarterly Report

Panacea Life Sciences Holdings, Inc. PLSH

0001493152-23-028898

← back to feed
Filed
Aug 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 2, 2023 17.65M sh
Shares Diluted Q2 2023 · Jun 30, 2023 17.65M sh
Shares Diluted Q2 2023 · Jun 30, 2023 17.65M sh
Shares Diluted Q2 2023 · Jun 30, 2022 14.97M sh
Shares Diluted Q2 2023 · Jun 30, 2022 14.97M sh
Capex Q2 2023 · Jun 30, 2023 $24.57K
Capex Q2 2023 · Jun 30, 2022 $17.6K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$797.17K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$1.17M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $8.19K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $6.95K
Stockholders Equity Q2 2023 · Jun 30, 2023 −$5.57M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$3.8M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$2.14M
Stockholders Equity restated Q2 2023 · Jun 30, 2022 $2.25M
Stockholders Equity Q2 2023 · Mar 31, 2022 $4.18M
Stockholders Equity Q2 2023 · Dec 31, 2021 $7.1M
Current Liabilities Q2 2023 · Jun 30, 2023 $17.05M
Current Liabilities Q2 2023 · Dec 31, 2022 $15.07M
Total Liabilities Q2 2023 · Jun 30, 2023 $23.42M
Total Liabilities Q2 2023 · Dec 31, 2022 $21.63M
Current Assets Q2 2023 · Jun 30, 2023 $5.75M
Current Assets Q2 2023 · Dec 31, 2022 $6.38M
Total Assets Q2 2023 · Jun 30, 2023 $17.85M
Total Assets Q2 2023 · Dec 31, 2022 $19.49M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.11
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.21
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.13
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.32
Eps Basic Q2 2023 · Jun 30, 2023 −$0.11
Eps Basic Q2 2023 · Jun 30, 2023 −$0.21
Eps Basic Q2 2023 · Jun 30, 2022 −$0.13
Eps Basic Q2 2023 · Jun 30, 2022 −$0.32
Sga Expense Q2 2023 · Jun 30, 2023 $145.21K
Sga Expense Q2 2023 · Jun 30, 2023 $392.63K
Sga Expense restated Q2 2023 · Jun 30, 2022 $204.68K
Sga Expense Q2 2023 · Jun 30, 2022 $665.23K
Net Income Q2 2023 · Jun 30, 2023 −$1.86M
Net Income Q2 2023 · Jun 30, 2023 −$3.66M
Net Income Q2 2023 · Jun 30, 2022 −$1.96M
Net Income Q2 2023 · Jun 30, 2022 −$4.74M
Operating Income Q2 2023 · Jun 30, 2023 −$1.07M
Operating Income Q2 2023 · Jun 30, 2023 −$2.36M
Operating Income Q2 2023 · Jun 30, 2022 −$1.24M
Operating Income Q2 2023 · Jun 30, 2022 −$2.89M
Gross Profit Q2 2023 · Jun 30, 2023 $202.81K
Gross Profit Q2 2023 · Jun 30, 2023 $428.42K
Gross Profit Q2 2023 · Jun 30, 2022 $137.97K
Gross Profit Q2 2023 · Jun 30, 2022 $238.36K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $196.31K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $648.19K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $331.5K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $697.59K
Revenue Q2 2023 · Jun 30, 2023 $399.13K
Revenue Q2 2023 · Jun 30, 2023 $1.08M
Revenue Q2 2023 · Jun 30, 2022 $469.47K
Revenue Q2 2023 · Jun 30, 2022 $935.95K